Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Rani Therapeutics Holdings, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
   10-K8-K10-K8-K10-KS-1
Net income  -30.6-63.3-8.3-53.10.00.0
Depreciation and amortization   [+]0.5 0.5 0.60.6
Stock-based compensation  15.8 22.6   
Change in working capital   [+]1.3 -3.4 1.0-0.4
Other operating activities  -33.5 -43.6 -16.6-26.5
Cash from operations  -46.5 -32.2 -15.0-26.3
   
Capital expenditures  -1.6 -0.5 -1.2-1.6
Purchases of short-term investments, net  -70.8     
Other cash from investing       0.0
Cash from investing  -72.4 -0.5 -1.2-1.5
   
Issuance of common stock, net    73.6   
Financing costs  -0.3     
Other cash from financing  28.7 3.5 72.70.9
Cash from financing  29.0 77.1 72.70.9
   
Free cash flow  -48.1 -32.8 -16.2-27.8
        Per share (diluted)  ($2.02) ($1.68)   
   
Cash paid for interest  0.0 0.3 0.1 
Cash paid for income taxes  0.7 0.1   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy